Bryn Mawr Trust CO Abbott Laboratories Transaction History

Bryn Mawr Trust CO

$2.54 Billion
Q1 2024

A detailed history of Bryn Mawr Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Bryn Mawr Trust CO holds 250,325 shares of ABT stock, worth $25.5 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

250,325

Previous 257,786 2.89%

Holding current value

$25.5 Million

Previous $25 Million 13.96%

% of portfolio

1.12%

Previous 1.14%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $817,128 - $902,482	-7,461 Reduced 2.89%	250,325 $28.5 Million
Q3 2023 Nov 15, 2023	BUY	$95.53 - $114.62 $129,443 - $155,310	1,355 Added 0.53%	257,786 $25 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $336,705 - $375,160	-3,341 Reduced 1.29%	256,431 $28 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $215,126 - $253,216	-2,221 Reduced 0.85%	259,772 $26.3 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $548,115 - $643,024	-5,766 Reduced 2.15%	261,993 $28.8 Million

Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $850,810 - $985,079	-8,793 Reduced 3.18%	267,759 $25.9 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $746,233 - $901,958	-7,311 Reduced 2.58%	276,552 $30 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $920,597 - $1.12 Million	-8,074 Reduced 2.77%	283,863 $33.6 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $760,533 - $931,231	-6,583 Reduced 2.21%	291,937 $41.1 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $757,590 - $838,115	-6,494 Reduced 2.13%	298,520 $35.3 Million
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $768,141 - $904,212	-7,261 Reduced 2.33%	305,014 $35.4 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $1.08 Million - $1.27 Million	-9,925 Reduced 3.08%	312,275 $37.4 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $1.86 Million - $2.03 Million	-17,716 Reduced 5.21%	322,200 $35.3 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $1.51 Million - $1.84 Million	-16,518 Reduced 4.63%	339,916 $37 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $2.84 Million - $3.63 Million	-37,063 Reduced 9.42%	356,434 $32.6 Million
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $23,243 - $33,988	370 Added 0.09%	393,497 $31.1 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $110,856 - $123,408	-1,412 Reduced 0.36%	393,127 $34.1 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $297,324 - $322,392	-3,633 Reduced 0.91%	394,539 $33 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $803,429 - $937,040	-11,024 Reduced 2.69%	398,172 $33.5 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $1.2 Million - $1.45 Million	-18,162 Reduced 4.25%	409,196 $32.7 Million
Q4 2018 Feb 15, 2019	BUY	$65.56 - $74.27 $65,822 - $74,567	1,004 Added 0.24%	427,358 $30.9 Million
Q3 2018 Aug 28, 2019	BUY	$60.81 - $73.36 $2,432 - $2,934	40 Added 0.01%	426,354 $31.3 Million
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $137,856 - $166,307	-2,267 Reduced 0.53%	426,314 $31.3 Million
Q2 2018 Aug 28, 2019	BUY	$57.57 - $63.54 $2,302 - $2,541	40 Added 0.01%	428,581 $26.1 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $215,369 - $237,703	-3,741 Reduced 0.87%	428,541 $26.1 Million
Q1 2018 Aug 28, 2019	BUY	$56.27 - $63.62 $4,501 - $5,089	80 Added 0.02%	432,282 $25.9 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $410,658 - $464,298	-7,298 Reduced 1.66%	432,202 $25.9 Million
Q4 2017 Aug 28, 2019	BUY	$53.68 - $57.47 $4,294 - $4,597	80 Added 0.02%	439,500 $25.1 Million
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $194,804 - $208,558	-3,629 Reduced 0.82%	439,420 $25.1 Million
Q3 2017 Aug 28, 2019	SELL	$48.06 - $53.64 $28,836 - $32,184	-600 Reduced 0.14%	443,049 $23.6 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $21.3 Million - $23.8 Million	443,649	443,649 $23.7 Million

Others Institutions Holding ABT

# of Institutions

3,118

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Abbott Laboratories Transaction History